Lee Jennifer Kayden has filed 90 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 32500 shares of RHYTHM PHARMACEUTICALS, INC. ($RYTM) on February 11, 2026.
Activity breakdown: 0 open-market purchases and 35 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Stock Options (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 64,984,361 | 9999.99% | 0.05% |
| Feb. 11, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Restricted Stock Units | 21650 | $0.00 | 21,650.0000 | 64,984,361 | 9999.99% | 0.03% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | F | Common Stock | 9237 | $108.99 | 19,233.0000 | 64,984,361 | 32.44% | 0.01% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 22612 | $0.00 | 28,470.0000 | 64,984,361 | 386.00% | 0.03% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 9163 | $0.00 | 27,487.0000 | 64,984,361 | 25.00% | 0.01% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 4512 | $0.00 | 4,512.0000 | 64,984,361 | 50.00% | 0.01% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 5500 | $0.00 | 11,000.0000 | 64,984,361 | 33.33% | 0.01% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 3437 | $0.00 | 0.0000 | 64,984,361 | 100.00% | 0.01% |
| Feb. 16, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 5500 | $0.00 | 16,500.0000 | 60,995,204 | 25.00% | 0.01% |
| Feb. 14, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Restricted Stock Units | 36650 | $0.00 | 36,650.0000 | 60,995,204 | 9999.99% | 0.06% |
| Feb. 19, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 2035 | $57.22 | 5,858.0000 | 60,995,204 | 25.78% | 0.00% |
| Feb. 16, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 5500 | $0.00 | 7,893.0000 | 60,995,204 | 229.84% | 0.01% |
| Feb. 14, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Stock Options (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 60,995,204 | 9999.99% | 0.09% |
| Feb. 12, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 10 | $56.41 | 4,803.0000 | 60,995,204 | 0.21% | 0.00% |
| Feb. 12, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1205 | $56.39 | 3,598.0000 | 60,995,204 | 25.09% | 0.00% |
| Feb. 13, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1205 | $58.00 | 2,393.0000 | 60,995,204 | 33.49% | 0.00% |
| Feb. 12, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 600 | $56.39 | 4,813.0000 | 60,995,204 | 11.08% | 0.00% |
| Feb. 9, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 4189 | $0.00 | 21,601.0000 | 60,995,204 | 16.24% | 0.01% |
| Feb. 11, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 2031 | $0.00 | 0.0000 | 60,995,204 | 100.00% | 0.00% |
| Feb. 11, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 4 | $57.50 | 5,413.0000 | 60,995,204 | 0.07% | 0.00% |
| Feb. 11, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1023 | $57.51 | 5,417.0000 | 60,995,204 | 15.89% | 0.00% |
| Feb. 11, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 2031 | $0.00 | 6,440.0000 | 60,995,204 | 46.06% | 0.00% |
| Feb. 10, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 2295 | $59.34 | 4,409.0000 | 60,995,204 | 34.23% | 0.00% |
| Feb. 10, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1894 | $58.39 | 6,704.0000 | 60,995,204 | 22.03% | 0.00% |
| Feb. 9, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 3437 | $0.00 | 4,409.0000 | 60,995,204 | 353.60% | 0.01% |
| Feb. 9, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 4189 | $6.80 | 8,598.0000 | 60,995,204 | 95.01% | 0.01% |
| Feb. 9, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 3437 | $0.00 | 3,437.0000 | 60,995,204 | 50.00% | 0.01% |
| Feb. 5, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 200 | $61.95 | 972.0000 | 60,995,204 | 17.06% | 0.00% |
| Feb. 5, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1133 | $61.01 | 1,172.0000 | 60,995,204 | 49.15% | 0.00% |
| Feb. 5, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1733 | $60.08 | 2,305.0000 | 60,995,204 | 42.92% | 0.00% |
| Feb. 1, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 4513 | $0.00 | 9,024.0000 | 60,995,204 | 33.34% | 0.01% |
| Feb. 4, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1447 | $59.43 | 4,038.0000 | 60,995,204 | 26.38% | 0.00% |
| Feb. 1, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 4513 | $0.00 | 5,485.0000 | 60,995,204 | 464.30% | 0.01% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 28717 | $0.00 | 71,283.0000 | 61,219,918 | 28.72% | 0.05% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 11642 | $0.00 | 37,108.0000 | 61,219,918 | 23.88% | 0.02% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 11642 | $30.66 | 67,833.0000 | 61,219,918 | 20.72% | 0.02% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 38051 | $65.68 | 29,782.0000 | 61,219,918 | 56.10% | 0.06% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 17540 | $66.95 | 12,242.0000 | 61,219,918 | 58.89% | 0.03% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 11070 | $67.56 | 1,172.0000 | 61,219,918 | 90.43% | 0.02% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 200 | $68.43 | 972.0000 | 61,219,918 | 17.06% | 0.00% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 20622 | $0.00 | 25,790.0000 | 61,219,918 | 44.43% | 0.03% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 20622 | $6.80 | 27,474.0000 | 61,219,918 | 300.96% | 0.03% |
| Nov. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 28717 | $24.29 | 56,191.0000 | 61,219,918 | 104.52% | 0.05% |
| March 20, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 9066 | $39.33 | 6,852.0000 | 57,673,128 | 56.95% | 0.02% |
| March 20, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 9169 | $38.22 | 15,918.0000 | 57,673,128 | 36.55% | 0.02% |
| March 19, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 15515 | $39.22 | 25,087.0000 | 57,673,128 | 38.21% | 0.03% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Common Stock | 33750 | $0.00 | 40,602.0000 | 57,673,128 | 492.56% | 0.06% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 57,673,128 | 9999.99% | 0.12% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | A | Restricted Stock Units | 22000 | $0.00 | 22,000.0000 | 57,673,128 | 9999.99% | 0.04% |
| Feb. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 3438 | $0.00 | 6,874.0000 | 57,673,128 | 33.34% | 0.01% |
| Feb. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 3438 | $0.00 | 6,459.0000 | 57,673,128 | 113.80% | 0.01% |
| Feb. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 2031 | $0.00 | 8,490.0000 | 57,673,128 | 31.44% | 0.00% |
| Feb. 12, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1023 | $51.38 | 7,467.0000 | 57,673,128 | 12.05% | 0.00% |
| Feb. 13, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 615 | $49.83 | 6,852.0000 | 57,673,128 | 8.24% | 0.00% |
| Feb. 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 2031 | $0.00 | 2,031.0000 | 57,673,128 | 50.00% | 0.00% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Restricted Stock Units | 4513 | $0.00 | 13,537.0000 | 57,673,128 | 25.00% | 0.01% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 4513 | $0.00 | 4,513.0000 | 57,673,128 | 9999.99% | 0.01% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1492 | $45.06 | 3,021.0000 | 57,673,128 | 33.06% | 0.00% |
| Nov. 14, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 13677 | $32.01 | 0.0000 | 57,874,960 | 100.00% | 0.02% |
| Nov. 14, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 12030 | $6.80 | 13,677.0000 | 57,874,960 | 730.42% | 0.02% |
| Nov. 14, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 12030 | $0.00 | 46,412.0000 | 57,874,960 | 20.58% | 0.02% |
| Nov. 8, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 3479 | $28.64 | 3,880.0000 | 57,874,960 | 47.28% | 0.01% |
| Nov. 8, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 5712 | $6.80 | 7,359.0000 | 57,874,960 | 346.81% | 0.01% |
| Nov. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 3438 | $6.80 | 5,085.0000 | 57,874,960 | 208.74% | 0.01% |
| Nov. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1719 | $27.37 | 3,366.0000 | 57,874,960 | 33.81% | 0.00% |
| Nov. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1719 | $28.00 | 1,647.0000 | 57,874,960 | 51.07% | 0.00% |
| Nov. 8, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 5712 | $0.00 | 61,880.0000 | 57,874,960 | 8.45% | 0.01% |
| Nov. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 3438 | $0.00 | 58,442.0000 | 57,874,960 | 5.56% | 0.01% |
| Nov. 8, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 2233 | $29.31 | 1,647.0000 | 57,874,960 | 57.55% | 0.00% |
| Nov. 3, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 80 | $0.00 | 67,592.0000 | 57,874,960 | 0.12% | 0.00% |
| Nov. 3, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 80 | $28.00 | 1,647.0000 | 57,874,960 | 4.63% | 0.00% |
| Nov. 3, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 80 | $6.80 | 1,727.0000 | 57,874,960 | 4.86% | 0.00% |
| Sept. 5, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 4519 | $6.80 | 7,813.0000 | 56,867,662 | 137.19% | 0.01% |
| Sept. 5, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 6166 | $28.05 | 1,647.0000 | 56,867,662 | 78.92% | 0.01% |
| Sept. 5, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 4519 | $0.00 | 67,672.0000 | 56,867,662 | 6.26% | 0.01% |
| Aug. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 1718 | $0.00 | 72,191.0000 | 56,867,662 | 2.32% | 0.00% |
| Aug. 7, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 8591 | $6.80 | 14,517.0000 | 56,867,662 | 144.97% | 0.02% |
| Aug. 7, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 11223 | $24.18 | 3,294.0000 | 56,867,662 | 77.31% | 0.02% |
| Aug. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Common Stock | 1718 | $6.80 | 5,012.0000 | 56,867,662 | 52.16% | 0.00% |
| Aug. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | S | Common Stock | 1718 | $24.66 | 3,294.0000 | 56,867,662 | 34.28% | 0.00% |
| Aug. 7, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Lee Jennifer Kayden | EVP, Head of North America | M | Stock Option (Right to Buy) | 8591 | $0.00 | 73,909.0000 | 56,867,662 | 10.41% | 0.02% |
| Feb. 11, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | M | Common Stock | 2031 | $0.00 | 5,575.0000 | 52,120,701 | 57.31% | 0.00% |
| Feb. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | S | Common Stock | 1204 | $27.51 | 3,544.0000 | 52,120,701 | 25.36% | 0.00% |
| Feb. 11, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | M | Restricted Stock Units | 2031 | $0.00 | 4,062.0000 | 52,120,701 | 33.33% | 0.00% |
| Feb. 14, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | S | Common Stock | 635 | $26.87 | 4,940.0000 | 52,120,701 | 11.39% | 0.00% |
| Feb. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | M | Restricted Stock Units | 3438 | $0.00 | 10,312.0000 | 52,120,701 | 25.00% | 0.01% |
| Feb. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | M | Common Stock | 3438 | $0.00 | 4,748.0000 | 52,120,701 | 262.44% | 0.01% |
| Feb. 9, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | S | Common Stock | 1192 | $27.66 | 3,556.0000 | 52,120,701 | 25.11% | 0.00% |
| Feb. 1, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | A | Restricted Stock Units | 18050 | $0.00 | 18,050.0000 | 52,120,701 | 9999.99% | 0.03% |
| Feb. 1, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Chien Jennifer | EVP, Head of North America | A | Stock Option (Right to Buy) | 46900 | $0.00 | 46,900.0000 | 52,120,701 | 9999.99% | 0.09% |